ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » ARNA Stock Price » ARNA Stock News

Arena Share News

 Arena Pharmaceuticals (mm) Stock Price
ARNA Stock Price
 Arena Pharmaceuticals (mm) Stock Chart
ARNA Stock Chart
 Arena Pharmaceuticals (mm) Stock News
ARNA Stock News
 Arena Pharmaceuticals (mm) Company Information
ARNA Company Information
 Arena Pharmaceuticals (mm) Stock Trades
ARNA Stock Trades

Arena, Eisai Diet Drug Less Concentrated In Human Brain Than Rat

By Thomas Gryta Of DOW JONES NEWSWIRES NEW YORK -(Dow Jones)- Arena Pharmaceuticals Inc. (ARNA) and Eisai Co. (ESALY, 4523.TO) said that a study of the diet pill lorcaserin showed that the drug seems to concentrate in the human brain less than it does in rats. The data is part of the companies' work to respond to Food and Drug Administration concerns that led to the pill being rejected for approval last year. The agency requested multiple sets of new data including studies related to breast cancer and brain cancer occurring in rats, and more information on heart-related risk. The company said that the effort to address other FDA concerns is ongoing. Arena conducted the study by measuring lorcaserin concentrations in human cerebrospinal fluid and then seeing how that compared to the amount of the drug in blood plasma. The company used an "apparent consistent relationship" of the amount of lorcaserin in the brain in relation to the spinal fluid of mice, rats and monkeys. That ratio was used to predict the corresponding amount of the drug in the human brain using the spinal fluid measurements. Using the new data and previous information, Arena estimates that human brain exposure to the drug is 1.7 times the plasma concentration at normal dose. In rats with a much higher dose, but which didn't have brain cancer, the ratio was 24 times. Arena noted that its estimates in the study are based on "certain assumptions and extrapolations" and the FDA may have different findings when looking at the raw data. The agency also may not view the company estimates as "reliable or predictive of the safety margin," Arena said in a statement. -By Thomas Gryta, Dow Jones Newswires; 212-416-2169; thomas.gryta@dowjones.com

Stock News for Arena (ARNA)
DateTimeHeadline
11/15/201309:18:03OZ Management LP 3Q 13F: Largest Purchases -2-
11/15/201309:18:02OZ Management LP 3Q 13F: Largest Purchases
11/15/201308:27:55S.A.C. Capital Advisors LP 3Q 13F: Largest Eliminations
11/15/201308:27:52S.A.C. Capital Advisors LP 3Q 13F: Largest -2-
11/15/201308:27:52S.A.C. Capital Advisors LP 3Q 13F: Largest Sales
11/15/201308:27:52S.A.C. Capital Advisors LP 3Q 13F: Largest Purchases
01/17/201309:20:44U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH
01/07/201311:14:02Vivus's Free Promotion Lifts Prescriptions for Diet Drug
12/05/201215:02:25FDA Approves Highest Number of New Drugs Since 2004
07/19/201217:15:53Vivus Shares Drop Amid Report Questioning Diet Drug's Prospects
05/11/201217:25:10Dow Drops After JP Morgan Trading Loss; Consumer Sentiment Rises
03/26/201217:00:06US Stocks Erase Last Week's Losses; S&P Ends With Nearly Four-Year...
03/26/201209:12:54US STOCK FUTURES: HOT STOCKS TO WATCH
01/11/201209:09:45US Stock Futures: HOT STOCKS TO WATCH
01/10/201209:03:04Arena: FDA Accepts Resubmitted Application For Weight-Loss Drug...
11/22/201111:14:30Registration Effectiveness Orders Issued By The SEC
08/02/201107:29:39Arena, Eisai Diet Drug Less Concentrated In Human Brain Than...
02/17/201109:07:03Orexigen Financial Chief Cooper Resigns
02/10/201117:54:48Arena Pharma Finance Chief Hoffman To Leave Company
02/01/201116:14:46Diet Drug Decision Shows Why Drug Makers Have Kept Distance

Arena Pharmaceuticals and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad